Affiliation:
1. University of South Australia, North Terrace, Adelaide, South Australia.
Abstract
The research reported here sought to identify and illuminate the reasons for the low adoption of pharmacogenetic tests in Australia. The research initially established possible reasons and propositions drawn from previous studies and surveys on the problem in Europe and the literature on the adoption of innovations. A small-scale exploratory, qualitative study was undertaken in one state in Australia; clinicians and other stake-holders were interviewed about their use of or support for pharmacogenetic tests. The expected, quite extensive individual factors known to influence adoption and rejection of innovations were found to be present in the situations covered. The reasons for nonadoption that were found in previous surveys were also supported. Some other, possibly critical, reasons were also identified. The implications from this initial exploration are discussed and the prospects for the increased use of the tests proposed.
Subject
Pharmacology,Molecular Medicine,General Medicine
Reference22 articles.
1. Pharmacogenetics and the practice of medicine
2. Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?
3. Integrating pharmacogenetics into society: in search of a model
4. MartinPA, Lewis G, Smart A, Webster A:False Positive? Prospects for the Clinical and Commercial Development of Pharmacogenetics.University of Nottingham/University of York, UK (2006).
5. The Royal Society:Personalised Medicines: Hopes and Realities.The Royal Society, London, UK (2005).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献